“Cannabis pills” have been legally sold in Europe for the first time. The capsules, which are available to buy online, could offer health benefits to people with diabetes.
There is substantial evidence to suggest that Cannabidiol (CBD), a compound found in cannabis, has beneficial effects on a number of health conditions, including chronic pain, cancer, anxiety, diabetes, epilepsy, rheumatoid arthritis, PTSD, sleep disorders, and heart disease.
For people with diabetes, research suggests that CBD reduces the pain of neuropathy and lowers blood glucose levels. It can also benefit some diabetic complications, including glaucoma.
The pills, which are sold by MMJ PhyoTech of Australia, does not provide the “high” of smoking cannabis, which is caused by tetrahydrocannabinol (THC). They contain only CBDCBD, which is the specific compound linked to health benefits.
The capsules are manufactured in Switzerland and registered in Germany. They can be purchased in Europe on the company’s website. A 10mg box can be purchased for €89.00 (or £65.66). a 100mg box costs €579.00 (or £427.22).
“MMJ is very happy with this landmark accomplishment and we leave the month of August with significant momentum,” said Tomas Edvinsso, CEO of Satipharm.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…